Questions raised over efficacy of cutting-edge new migraine drugs

Last year erenumbab was approved by the FDA, the first in an entirely new class of drugs designed to help migraine sufferers to reach the general public. A study is now reporting successful Phase 3 clinical trial results for a new orally admi… Continue reading Questions raised over efficacy of cutting-edge new migraine drugs